Tag: Global Data
Clinical data disclosure critical for Bharat Biotech Covid-19 intranasal vaccine success:...
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, as of 22 August 2022 there are currently nine COVID-19 intranasal vaccines in Phase I and later stages of clinical development in different parts of the world
APAC News: Japan inches closer to having its own indigenous Covid-19...
Delay in launch of indigenous COVID-19 vaccines by Japanese pharma will impact domestic market potential
Small biotech companies dominate the pipeline for Microbiome-targeted therapies, says GlobalData
GlobalData anticipates ample opportunities for therapies targeting the skin microbiome as there are only three pipeline therapies in clinical development................
Pricing adjustments for CAR-T therapies likely to take place in 2018,...
A fairly comprehensive study reported in February 2018 on the Health Affairs Blog claims that Novartis could lower the price of Kymriah by two-thirds and still achieve a profit..................